<DOC>
	<DOCNO>NCT02055170</DOCNO>
	<brief_summary>The purpose study study effect hormone therapy ( androgen pathway modification ) outcomes patient lung cancer . This information may benefit future treatment strategy , prevention control . In study , protein testosterone bind , call androgen receptor ( AR ) , measure sample patient 's biopsy surgical tumor sample . The investigator look marker fast cancer grow ( Ki67 ) use finasteride biopsy specimen . Finasteride take day consent day patient 's surgery . This marker measure use finasteride surgical specimen . The investigator look decrease Ki67 patient 's biopsy specimen surgical specimen indicator medication block tumour growth .</brief_summary>
	<brief_title>Neoadjuvant Finasteride Patients With Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>male age &gt; 18 biopsyproven nonsmall cell lung cancer surgical intervention plan current use 5alpha reductase inhibitor previous diagnosis prostate cancer previous hypersensitivity 5alpha reductase inhibitor</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>